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Abstract 
Diacyl glycerols and phorbol esters, which activate protein kinases C, stimulated Ehrlich ascites tumor cell ferricyanide reductase 
activity. On the contrary, selective inhibition of active protein kinases C with bis-indolyl maleimide did not change the rate of 
ferricyanide reduction by E]~rlich cells. Selective inhibitors of phosphoprotein phosphatases, okadaic acid and cyclosporin A, also 
stimulated plasma membrane r dox system. Taking all these data together, protein kinases or phosphoprotein phosphatases seemed to be 
involved in the multiple and complex regulation of Ehrlich cell plasma membrane r dox system. 
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1. Introduction 
Plasma membrane redox systems (PMRS) have been 
found out to be ubiquitous ([1,2] and references therein). 
PMRS have been related I:o several vital functions, includ- 
ing energization of organic solute transport and control of 
cell growth [3,1]. In our lab, a plasma membrane ferri- 
cyanide reductase activity has been studied in whole Ehrlich 
ascites tumor cells [4,5], in native plasma membrane vesi- 
cles [6-8], and in reconstituted proteoliposomes [9], and 
very recently it has been purified to apparent homogeneity 
[10]. Once fulfilled the molecular approach to the study of 
PMRS, we decided to go back to the regulation of PMRS 
in whole cells. Since PMRS seems to play a role in growth 
control, it has to be somehow integrated in the sequence of 
events leading to the modulation of cell growth by both 
external and internal signals. In fact, hormones and growth 
factors have been demonstrated to modulate PMRS activ- 
ity [1,11]. Further, N-myc and Ha-ras oncogene expres- 
sions seem to correlate with PMRS activity [11,12]. Re- 
cently, PMRS has been related to the ras signaling path- 
way [ 12,13], and cAMP and heterotrimeric G proteins have 
been demonstrated to be involved in the regulation of 
PMRS [14,15]. Despite of all this fragmentary information, 
to our knowledge no comprehensive approach to the study 
of the involvement of different signal transduction path- 
ways in the control of PMRS activities has been carried 
out up to now. In an effort to cover this gap, we have 
postulated that Ehrlich cell PMRS should be controlled by 
a complex and multiple mechanism involving different 
signal transduction pathways and we have begun to test 
this postulate. In fact, we have recently reported that 
cGMP and Ca 2+ are two second messenger involved in the 
modulation of Ehrlich cell PMRS activity [16]. We have 
also obtained evidence for the involvement of cytoplasmic 
pH as a modulator of Ehrlich cell PMRS activity (unpub- 
lished data). In this report, we support evidence for the 
involvement of protein kinases C and phosphoprotein 
phosphatases in the regulation of Ehrlich cell PMRS. 
2. Materials and methods 
2.1. Cells 
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Hyperdiploid Lettr6 Ehrlich ascites tumor cells were 
grown in the peritoneal cavity of 2-month-old Swiss fe- 
male mice, and harvested as described elsewhere [17]. The 
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cells were harvested in the plateau phase of growth (9-11 
days after tumor inoculation), and they were washed and 
suspended in PBS, without or with 5 mM glucose added as 
the only substrate for long-term (up to 8 h) survival of 
harvested cells, as demonstrated by P&ez-Rodrfguez et al. 
[18]. 
2.2. Ferricyanide reductase assay in whole cells 
A discontinuous assay was carried out with 5 × 10 7 
cells/ml in the presence of 0.5 mM ferricyanide, as previ- 
ously described [4]. 
2.3. Treatments Time (min) 
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B Preincubation of 107 cells/ml were carried out during 
different imes, as follows: 20 min for cyclosporin A; and 
30 min for the rest of products tested. In all cases, the 
concentrations u ed were similar to those described in the 
biochemical literature which have shown the maximum 
effect. All the experiments were carried out with parallel 
controls in which the different drugs were omitted. After 
preincubation, cells were washed twice and suspended in 
PBS to carry out ferricyanide reductase assay as described 
above. 
3. Results and discussion 
The involvement of PMRS in important vital functions 
points to its role as a target of different biochemical 
signals. Thus, PMRS can be involved in downstream 
second messenger function by direct action on cytosolic 
components or by modification of other membrane n- 
zymes directly involved in messenger formation [19]. In 
this context, PMRS has been shown to activate certain 
protein kinases C [20]. On the other hand, PMRS seems to 
respond to upstream modulatory signals. The modulatory 
effects of extracellular signals, namely, hormones and 
growth factors on PMRS are well documented [1,11,21,22]. 
Much less is known concerning the role of intracellular 
signals and signal transducers on the modulation of PMRS 
activity. Ehrlich cells have proven to be a convenient 
model for these studies [16]. 
Several clues seem to indicate a role for certain protein 
kinases C in the control of PMRS. In fact, incubation of 
Ehrlich cells with the cell-permeable diacyl glycerol, sn- 
1,2-dioctanoyl glycerol [23], at 3 ~M final concentration 
produced a high increase in ferricyanide reductase activity 
(results not shown). Furthermore, a stimulation of this 
activity could also be detected upon incubation of Ehrlich 
cells with PMA, a phorbol ester that can substitute for 
diacyl glycerols and mimic their effect on protein kinases 
C [24]. As shown in Fig. 1A, PMA-treated cells reduced 
more ferricyanide than control, untreated cells. On the 
contrary, the use of bis-indolyl maleimide, a potent and 
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Fig. 1. Effects of protein kinase C modulators on Ehrlich cell plasma 
membrane redox system activity. Cells were preincubated in the absence 
(open symbols) or presence (closed symbols) of 162 nM PMA (Fig. IA) 
or 1 IxM bis-indolyl maleimide (Fig. 1B) as described in Section 2. 
Afterwards, the time-courses of ferricyanide reduction were followed. 
Experiments were replicated consistently three times with different batches 
of cells. Data are means of two different experiments. For PMA, values at 
10 and 20 min of incubation were significatively higher than those for 
their respective controls, according to a non-parametrical Mann-Whitney's 
U test (P < 0.05). On the contrary, values obtained in the experiments 
with bis-indolyl maleimide and their controls were undistinguisable. 
selective inhibitor of protein kinases C [25], produced no 
significant change in ferricyanide reductase activity, as 
compared with the values in the respective control experi- 
ments (see Fig. 1B). The picture that seems to emerge 
from these data is that PMRS could be stimulated by the 
activation of those protein kinases C commonly inactive; 
on the contrary, PMRS would not be sensitive to those 
protein kinases C which are active in the control situation. 
Taking into account the data shown by Malviya and 
Anglard [20], it seems that PMRS and protein kinases C 
mutually modulate ach other. 
It could be expected that phosphoprotein phosphatase 
inhibition would provide new arguments for the role at- 
tributed to protein phosphorylation i controling PMRS 
activity. In fact, the tumor promoter okadaic acid is a 
potent inhibitor of PP-2A [26,27]. On the other hand, the 
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Fig. 2. Effects of selective inhibitors of phosphoprotein phosphatases on
Ehrlich cell plasma membrane r dox system activity. Cells were preincu- 
bated in the absence (open symbols) or presence (closed symbols) of 0.1 
~M okadaic acid (A) or 1 txM cyclosporin A (B) as described in Section 
2. Afterwards, the time-courses of ferricyanide reduction were followed. 
Experiments were replicated consistently three times with different batches 
of cells. Typical results are depicted. Relative values of activity expressed 
as percentages, taking control values at each time as 100%, were signi- 
ficatively higher in treated cells than in control cells (P < 0.01 according 
to a non-parametrical Mann-Whitney's U test for all the times tested). 
immunosuppressor cyclosporin A has been also described 
as a potent and selective inhibitor of PP-2B [28]. Data in 
Fig. 2A and 2B indicate that inhibition of active phospho- 
protein phosphatases 2A and 2B produces a significant 
increase in Ehrlich cell PMRS activity. 
Data obtained with okadaic acid and PMA could have a 
second explanation, not necessarily incompatible with the 
first ones: both compounds would activate MAP kinases 
indirectly, as suggested by G6mez and Cohen [29]. 
It is noteworthy to keep in mind that previously pub- 
lished reports suggest a possible involvement of protein 
kinases A and tyrosine kinases in the control of certain 
PMRS activities [14,30]. 
The use of activators and inhibitors of intermediary 
steps in a signal transduction pathway can clarify the role 
of these steps in the sequence of events leading to a 
concrete response. Though no individual result can be 
considered as a conclusive vidence for the involvement of 
certain signal transduction pathways, the cummulative and 
coincident results shown here offer a congruent and consis- 
tent picture of a very complex and tightly regulated pro- 
cess. According to the key roles that seems to play in cell 
physiology, PMRS should be expected to be accurately 
regulated by more than one regulatory pathway. In fact, 
this is the main conclusion that could be obtained from the 
data given in this report. Many efforts remain to be done in 
order to elucidate the actual involvement of different sig- 
nal transduction pathways in the control of PMRS, as well 
as to determine with accuracy the sequence of events 
upstream and downstream of the PMRS. 
Finally, a consideration should be given to the fact that 
our results have been obtained in a model system that is a 
transformed, neoplastic ell. This fact raises the question 
whether similar mechanisms of control operate on PMRS 
of normal, non-transformed cells. In this context, it is 
noteworthy to note that Garcfa Cafiero [31] has reported 
that cultured normal iver cells do not respond to PMA but 
their PMRS is inhibited by H-7, a protein kinase C in- 
hibitor. 
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